We recently published a list of 10 Tech Stocks with High Upside Potential. In this article, we are going to take a look at ...
State Medicaid agencies can improve D-SNP financial transparency and reward those D-SNPs that provide the best value to ...
Dual eligibles — that is, people eligible for both Medicare and Medicaid — have a wealth of Medicare options. These ...
3d
Hosted on MSNSNPS Plunges 21% in a Year: Should You Hold or Fold the Stock?Synopsys SNPS shares plunged 20.8% over the past year, underperforming the Zacks Computer - Software industry, Zacks Computer ...
Synopsys (NASDAQ:SNPS – Free Report) had its price target decreased by Piper Sandler from $655.00 to $653.00 in a report released on Thursday,Benzinga reports. Piper Sandler currently has an ...
Synopsys Inc (NASDAQ:SNPS) shares are trading higher premarket reported first-quarter financial results after the market ...
In a report released today, Blair Abernethy from Rosenblatt Securities maintained a Buy rating on Synopsys (SNPS – Research Report), with a ...
Synopsys SNPS delivered better-than-expected first-quarter fiscal 2025 results. The company reported non-GAAP earnings of $3.03 per share for the first quarter, surpassing the Zacks Consensus ...
This post was written by Luke Carberry Mogan. SNPS' first-quarter performance is likely to have benefited from the rising adoption of EDA, IP solutions and Synopsys.ai platform. Get a deeper ...
Synopsys (SNPS) came out with quarterly earnings of $3.03 per share, beating the Zacks Consensus Estimate of $2.81 per share. This compares to earnings of $3.56 per share a year ago. These figures ...
Loop Capital Markets analyst Gary Mobley reiterated a Buy rating on Synopsys (SNPS – Research Report) today and set a price target of $650.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results